PFIZER
Back to Balance Sheet
|
PFIZER Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹570 Cr | ₹547 Cr | ₹657 Cr | ₹853 Cr | ₹774 Cr |
What is the latest Total Current Liabilities ratio of PFIZER ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹570 Cr |
| Mar2024 | ₹547 Cr |
| Mar2023 | ₹657 Cr |
| Mar2022 | ₹853 Cr |
| Mar2021 | ₹774 Cr |
How is Total Current Liabilities of PFIZER Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹570 Cr | 4.20 | |
| Mar2024 | ₹547 Cr | -16.85 | |
| Mar2023 | ₹657 Cr | -22.93 | |
| Mar2022 | ₹853 Cr | 10.14 | |
| Mar2021 | ₹774 Cr | - | |
Compare Total Current Liabilities of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹21,088.3 Cr | -3.3% | -11.3% | 13.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,000.0 Cr | -0.4% | 5.3% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,076.0 Cr | -4.3% | -6.3% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,510.0 Cr | 0.4% | 8.2% | 44.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,921.0 Cr | 0.5% | 1.8% | 16.4% | Stock Analytics | |
| CIPLA | ₹106,150.0 Cr | -0.8% | -2.6% | -9.2% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | -3.3% |
-11.3% |
13.4% |
| SENSEX | -5.5% |
-11.5% |
0.3% |
You may also like the below Video Courses